Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Lamin A/C Protein (LMNA)

LMNA Spezies: Human Wirt: Escherichia coli (E. coli) Recombinant > 90 % WB, SDS
Produktnummer ABIN2669331
  • Target Alle Lamin A/C (LMNA) Proteine anzeigen
    Lamin A/C (LMNA)
    Protein-Typ
    Recombinant
    Spezies
    • 5
    • 3
    • 2
    Human
    Quelle
    • 6
    • 2
    • 1
    • 1
    Escherichia coli (E. coli)
    Applikation
    Western Blotting (WB), SDS-PAGE (SDS)
    Produktmerkmale
    Recombinant human lamin A is a 645 amino acids protein with a molecular weight of 70 kDa.
    Reinheit
    > 90 %
    Top Product
    Discover our top product LMNA Protein
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    20 mM phosphate buffer pH 7.0, 0.5M NaCl, 1 mM DTT, 1.5 mM EDTA, 20 % (v/v) glycerol
    Lagerung
    -20 °C
  • Target
    Lamin A/C (LMNA)
    Andere Bezeichnung
    Lamin A (LMNA Produkte)
    Hintergrund
    Lamin A is a major component of the nuclear lamina, a dynamic meshwork located just under the nuclear envelope and it is encoded by lamin A/C gene (LMNA). Lamin A is synthesized as a longer precursor, prelamin A (code REP0038), that in vivo undergoes to serial post-translational modifications that lead to mature lamin A. Different mutations in the LMNA gene have been associated with different diseases that are collectively called laminophaties, including Emery-Dreifuss muscular dystrophy, familiar partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome.
    Pathways
    Apoptose, Caspase Kaskade in der Apoptose, ER-Nucleus Signaling, Protein targeting to Nucleus
Sie sind hier:
Kundenservice